Study design
head and neck cancer, thirty-four
ONCOLOGY, HEAD AND NECK CANCER
A two-arm parallel randomized, controlled clinical trial was conducted on thirty-four head and neck cancer patients of both genders who were planned to receive radiotherapy from February to September 2022. Patients were selected from the outpatient clinic of Department of Clinical Oncology, Faculty of Medicine, Alexandria University. Prior to the study, patients were given a detailed explanation of the study and signed an informed consent according to the guidelines of the Ethical Committee of the Faculty of Dentistry, Alexandria University. The study was completed according to the principles of the modified Helsinki’s code for human clinical studies (2013) and CONSORT 2010 guidelines for reporting randomized clinical trials. It was also approved by the Research Ethics committee of the Faculty of Dentistry, Alexandria University (IRB NO: 00010556-IORG0008839- 0290-09/2021) in September 2021, and has been registered at ClinicalTrials.gov on 28/01/2022, registration number: (NCT05214495), [